SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001013594-24-000074
Filing Date
2024-01-26
Accepted
2024-01-26 10:46:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 bti13g-121823.htm SC 13G 113691
  Complete submission text file 0001013594-24-000074.txt   115325
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88741 | Film No.: 24564968
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 853 BROADWAY SUITE 1109 NEW YORK NY 10003
Business Address 853 BROADWAY SUITE 1109 NEW YORK NY 10003 212-698-0710
Lepercq De Neuflize Asset Management LLC (Filed by) CIK: 0001854423 (see all company filings)

IRS No.: 020579227
Type: SC 13G